1449396-68-2

Upstream product

• 1287220-82-9 tert-butyl 4-{[4-chloro-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]amino}benzoate 
• 18144-47-3 tert-butyl 4-aminobenzoate 
• 1449396-65-9 methyl (S)-2-(4-{[4-(1-(4-chlorophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]amino}benzamido)-3-(2-(methylamino)-2-oxoacetamido)propanoate 
• 1360828-39-2 4-{[4-(1-(4-chlorophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]amino}benzoic acid 
• 1360828-52-9 methyl (S)-3-(tert-butoxycarbonylamino)-2-(4-{[4-(1-(4-chlorophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]amino}benzamido)propanoate 
• 185677-00-3 2,4-dichloro-6-(2,2,2-trifluoroethoxy)-1,3,5-triazine 
• 1449410-34-7 methyl (S)-3-amino-2-(4-{[4-(1-(4-chlorophenyl)cyclopropylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]amino}benzamido)propanoate 
• 1360828-40-5 tert-butyl 4-((4-((1-(4-chlorophenyl)cyclopropyl)amino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl)amino)benzoate 

Relevant academic research and scientific papers

Compounds for the Treatment of Hepatitis C

The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.